4/18
10:22 am
gpcr
Structure Therapeutics Inc. (NASDAQ: GPCR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
Low
Report
Structure Therapeutics Inc. (NASDAQ: GPCR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
4/18
09:51 am
gpcr
Rating for GPCR
Low
Report
Rating for GPCR
4/9
08:09 am
gpcr
Structure Therapeutics Inc. (NASDAQ: GPCR) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $65.00 price target on the stock.
Low
Report
Structure Therapeutics Inc. (NASDAQ: GPCR) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $65.00 price target on the stock.
4/9
07:02 am
gpcr
Rating for GPCR
Medium
Report
Rating for GPCR
4/9
06:16 am
gpcr
Structure Therapeutics initiated with bullish view at Cantor Fitzgerald
Medium
Report
Structure Therapeutics initiated with bullish view at Cantor Fitzgerald
3/8
01:01 pm
gpcr
Rating for GPCR
Low
Report
Rating for GPCR
3/8
01:01 pm
gpcr
Rating for GPCR
Low
Report
Rating for GPCR